{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:25:47Z","timestamp":1785464747006,"version":"3.56.0"},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T00:00:00Z","timestamp":1146096000000},"content-version":"vor","delay-in-days":4134,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[1995,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>This international, multicentre, randomized, double\u2010blind, double\u2010dummy, parallel\u2010group trial was undertaken to compare the efficacy and tolerability of once\u2010daily astemizole\u2010D (10mg astemizole plus 240 mg pseudoephedrine) with beclomethasone nasal spray (0.05mg\/ml) two puffs\/nostril administered twice daily in a total of 204 patients with seasonal allergic rhinitis. Treatment duration was 4 weeks, Although investigator assessments of symptom severity were generally comparable in the two treatment groups throughout the trial, statistically significant differences in favour of astemizole\u2010D for sneezing and ocular symptoms were apparent at the end of the 4\u2010week treatment period (<jats:italic>P<\/jats:italic> &lt; 0.05). Patient diary data support these findings, with significant differences in favour of the antihistamine\/decongestant combination reported for ocular symptoms after 2 weeks of treatment (<jats:italic>P<\/jats:italic> &lt; 0.05) and non\u2010significant trends for sneezing after 2 weeks and ocular symptoms over the entire treatment period (<jats:italic>P<\/jats:italic>= 0.07). Use of rescue medication for ocular symptoms was also significantly lower in the astemizole\u2010D treatment group (<jats:italic>P<\/jats:italic> &lt; 0.05). A wide range of adverse experiences were reported, however, there were no statistically significant differences in the type or incidence of those between the two treatment groups. In conclusion, astemizole\u2010D appears to be at least as effective and well tolerated as intranasal beclomethasone in the treatment of seasonal allergic rhinitis, providing at least comparable relief from all nasal symptoms including congestion and significantly greater relief from ocular symptoms than the topical steroid.<\/jats:p>","DOI":"10.1111\/j.1365-2222.1995.tb01003.x","type":"journal-article","created":{"date-parts":[[2006,4,28]],"date-time":"2006-04-28T14:51:54Z","timestamp":1146235914000},"page":"60-65","source":"Crossref","is-referenced-by-count":11,"title":["Oral antihistamine\/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis"],"prefix":"10.1111","volume":"25","author":[{"given":"A. C.","family":"NEGRINI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"TROISE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"VOLTOLINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"HORAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"BACHERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"JANSSENS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"1","article-title":"Epidemiology of hay fever and perennial allergic rhinitis","volume":"21","author":"Weeke ER.","year":"1987","journal-title":"Monogr Allergy"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(05)80223-4"},{"key":"e_1_2_1_4_2","first-page":"789","article-title":"Allergic rhinitis","volume":"76","author":"Badhwar AK","year":"1992","journal-title":"Clin Allergy"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(88)90031-0"},{"key":"e_1_2_1_6_2","first-page":"474","article-title":"Pharmacotherapy of allergic rhinitis","volume":"8","author":"Delafuente JC","year":"1989","journal-title":"Clin Pharmacol"},{"key":"e_1_2_1_7_2","first-page":"243","article-title":"Clinical evaluation of the safety and efficacy of astcmizole\/pseudocphedrine combination in the treatment of fall hayfever","volume":"85","author":"Fox R","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_8_2","first-page":"91","article-title":"Comparison of once\u2010daily astemizole\u2010pseudoephedrine combination with each component and a placebo in seasonal allergic rhinitis","volume":"64","author":"Grant JA","year":"1990","journal-title":"Ann Allergy"},{"key":"e_1_2_1_9_2","first-page":"237","article-title":"Double\u2010blind randomized multicentre trial of Hismanal\u2010D in seasonal allergic rhinitis","volume":"85","author":"Hampel F","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"e_1_2_1_10_2","first-page":"242","article-title":"Meta\u2010analysis of Hismanal\u2010D clinical trials in seasonal allergic rhinitis","volume":"47","author":"Grant JA","year":"1992","journal-title":"Allergy"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198428020-00002"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1983.tb02361.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998509109635"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1986.tb00766.x"},{"key":"e_1_2_1_15_2","first-page":"100","article-title":"The effect of astemizole, terfenadine and pseudoephedrine combinations on sleep in healthy volunteers","volume":"47","author":"Idzikowski C","year":"1992","journal-title":"Allergy"},{"key":"e_1_2_1_16_2","article-title":"Astemizole\u2010D causes less sleep impairment than loratadine\u2010D","author":"Janssens MML","journal-title":"Eur J Clin Pharmacol"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2222.1995.tb01003.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2222.1995.tb01003.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T04:42:15Z","timestamp":1698295335000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2222.1995.tb01003.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["10.1111\/j.1365-2222.1995.tb01003.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2222.1995.tb01003.x","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}